Life-Scienced Bites  

March Market Moves - Mastering Momentum with Modern Mindsets

As March unfurls, we dive deep into Singapore’s vibrant job market - where digital dynamism meets life sciences innovation. With the gears of progress turning steadily into 2025, we're here to share the pulse of progress, blending bold numbers and groundbreaking initiatives into a life-scienced bite for you, dear reader!

Here are the topics for the month!

• A Resilient Rhythm: Singapore’s Labour Landscape

• Life-Scienced News and Developments

• Star talents

A Resilient Rhythm: Singapore’s Labour Landscape

Singapore’s job market is striding confidently into 2025. The Q4 2024 Labour Market Report tells us that total employment surged by 44,500 jobs, while vacancies climbed to 77,500—a testament to the city-state’s robust demand for high-skilled talent. Despite a global climate of uncertainty, sectors like finance, IT, and healthcare continue to shine, powered by a proactive government focus on upskilling and AI-driven innovation. Read the report by Singapore’s Ministry of Manpower here.

Upskilling for the Future: The AI Advantage

As technology transforms our world, Singapore is at the forefront, championing lifelong learning and digital dexterity. With initiatives geared toward fostering AI, data science, and cybersecurity expertise, the country is primed to meet the demands of an AI-enhanced future. According to insights from HCAMAG, the hiring outlook for Q2 2025 is a promising 27% positive, underscoring a vibrant call for tech talent that fuels the engine of digital transformation. Singapore’s Minister of Digital Development and Information Josephine Teo’s statements on upskilling to stay relevant here.

Hiring Outlook for 2025

The Q2 2025 hiring outlook signals a strong demand for skilled talent in both technology and healthcare sectors, with companies increasingly focused on AI roles and digital health technologies. Despite global economic uncertainty, hiring in these sectors is projected to remain steady. Sectors like logistics, supply chain management, and professional services are also expected to see continued growth, as automation and AI solutions take center stage. Read more here!

Life Sciences: Biotech and Clinical Trials Leading Growth

Singapore’s life sciences sector is rapidly expanding, fueled by significant investments like the $300 million joint venture between SPRIM Global Investments and ONEIM, which aims to accelerate clinical trial financing. This sector is creating a wealth of opportunities for professionals in biotech research, clinical trial management, and medical device development. As the country positions itself as a leader in biopharma and clinical research, demand for talent in these areas will only increase, with the biotech ecosystem expected to thrive. Read more here.

Industries Likely to See Increased Demand

Several industries are poised for growth, with specific roles expected to see a surge in demand:

1. Technology: Roles in AI development, data science, cybersecurity, and cloud computing will remain at the forefront as companies continue their digital transformation.

2. Healthcare and Life Sciences: Positions like biotech researchers, clinical trial managers, medical device engineers, and pharmacovigilance specialists will be in high demand, driven by advancements in biopharma, personalized medicine, and health tech innovations.

3. Logistics and Supply Chain: As AI and automation reshape supply chains, roles in logistics management, supply chain analysis, and AI integration for logistics will see a rise in demand.

4. Professional Services: With a growing focus on digital transformation, companies will require more IT consultants, data analysts, and project managers to guide technological integration.

Conclusion: Marching Ahead with Confidence

March 2025 heralds a time of robust opportunity in Singapore’s job market, where the confluence of AI innovation, upskilling initiatives, and a flourishing life sciences sector creates a dynamic landscape ripe for growth. With strategic investments and a forward-thinking mindset, Singapore is not only adapting to global shifts - it’s setting the pace. For professionals ready to embrace change and invest in continuous learning, the future is bright, bold, and brimming with potential.

Stay tuned, dear reader, as we continue to unravel the threads of progress and innovation in the vibrant tapestry of Singapore’s evolving job market!

Life-Scienced News and Developments

As we step into March 2025, the world of life sciences is buzzing with fresh breakthroughs and transformative news. Join us as we uncover the latest stories, insights, and trends that promise to redefine the future of health and innovation in our ever-evolving landscape.

HEALTHCARE

• Singapore’s AI-Driven Revolution: Singapore is transforming healthcare by using AI-driven technologies to shift focus from reactive treatments to preventive care. The approach leverages big data and predictive analytics for early detection and personalized treatment, aiming to improve patient outcomes while reducing costs.

  Read more here.

• Singapore’s AI Lifeline for an Ageing Population: Singapore is turning to artificial intelligence to address the challenges of its rapidly ageing population. The initiative leverages data-driven insights to monitor health, provide early warnings, and optimize patient care, ultimately aiming to improve healthcare outcomes and enhance the quality of life for seniors.

  Read more here.

• Biotronik shifts focus to connected healthcare: Biotronik is adjusting its strategy to focus more on implantable devices, remote monitoring, and connected healthcare platforms. This shift reflects the growing demand for patient-centric technologies that enable continuous health monitoring and data collection. The move aligns with broader trends in the healthcare sector towards more integrated, tech-driven solutions.

  For more details, check out the full article here.

BIOTECHNOLOGY

• Singapore’s Biotech Boom: Singapore’s biotech industry is flourishing, driven by strategic investments and government initiatives. The nation is emerging as a regional leader, leveraging a robust infrastructure and regulatory frameworks to support growth in biopharma and medical technologies. Increased funding and global partnerships are fueling this innovation-driven sector, positioning Singapore as a premier hub for biotechnology.

  Read more here.

• Biotech rally boosted by Novartis’s breakthrough in SMA: Novartis is making waves in biotech with its new treatment for spinal muscular atrophy (SMA), which has sparked a rally in the sector. The news highlights a major milestone in genetic therapies and has positively impacted investor sentiment toward biotech firms. This development underscores the ongoing progress in rare disease treatments and the growing potential of gene therapies.

  For more details, read the full article here.

PHARMACEUTICALS 

• Hyphens Pharma secures exclusive rights to supply key drug in Singapore: Hyphens Pharma has gained exclusive distribution rights for a vital drug in Singapore, marking a significant move in expanding its portfolio. This agreement positions the company as a key player in specialty pharmaceuticals and strengthens its presence in the local healthcare market. The strategic deal reflects the ongoing trend of pharmaceutical companies securing exclusive rights to critical therapies.

  For more details, read the full article here.

• EU plans to reduce reliance on Asia for antibiotics and critical drugs: The EU has announced plans to reduce its dependence on Asia for the supply of essential medicines, including antibiotics. This move aims to enhance drug security by diversifying production sources within Europe. The initiative highlights the growing concerns over global supply chain vulnerabilities and seeks to ensure the EU’s long-term access to critical healthcare resources.

  For more details, read the full article here.

MEDTECH

• A*Star launches MedTech Catapult: Singapore’s A*Star has launched a S$38 million MedTech Catapult to support the commercialization of medical devices. This initiative aims to boost innovation and collaboration between startups and SMEs, helping them bring medical technologies to market faster. The program is designed to strengthen Singapore’s role as a key MedTech hub in Asia.

  For more details, read the full article here.

Star Talents

The Life Science division is always on the lookout to furnish their roster with the experienced and insightful talents. Here, we highlight some of the star talents in our pool who are passively and actively looking for new opportunities.

If you are looking for top-notch individuals to join your team, let us know and we can discuss how we can bring such talents to you!

ACLS1002504 | Medical Affairs & Clinical Leader | Circa $250,000
Pharmaceuticals & Medical Devices | Global Strategy & R&D
Open to relocate | Immediate

ACLS1002507 | Head of Marketing | Circa $180,000
Aesthetics & Pharmaceuticals | Marketing Strategy
Open to relocate | Immediate

ACLS1002508 | Regional Commercial Director | Circa $300,000
FMCG & MedTech & Pharmaceuticals | Commercial & Marketing Strategy
Open to relocate | Immediate

ACLS1002512 | R&D Quality Director | Circa $200,000
Pharmaceuticals | Quality, Process Excellence
Open to relocate | Immediate

ACLS1002513 | Regional Head | Circa $250,000
MedTech & Medical Devices | Commercial & Marketing Strategy, Sales
Open to relocate | 2 months

Contact Us: [email protected]
Mobile: +65 9116 7743 Office: +65 6590 9942

Have a free copy of our 2025 Salary Guide, please make a request here.